Duncan Barbara Gayle - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 16, 2024, Duncan Barbara Gayle's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Director, and currently has 33,150 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVIR insiders.
Data Source: SEC.
Duncan Barbara Gayle - Insider Non-Derivative Transactions at AVIR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 17, 2024 | M -- (Common Stock) | 33150 | 0 | 33150 |